07:47:03 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 Ordinarie utdelning CSMED 0.00 DKK
2024-02-29 Årsstämma 2024
2024-02-14 Bokslutskommuniké 2023
2023-12-15 Ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 Ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 Ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-03-22 10:37:47

CS MEDICA A/S ("CS MEDICA" or the "Company") announces today that the products CANNASEN®CBD Pain Patch, Protective Nasal Gel and CBD PSOR+ATOPIC Lotion have been launched on Matas webshop and are now available for online sales. The previous product availability on Matas included the medical devices CANNASEN®CBD Arthritis Gel, Psoriasis Gel, Anti-Hair Loss Serum and Hand Cream.

CS MEDICA has lately been working on extending the Company's product availability to be able to sell and distribute CANNANSEN products through more channels. Currently, CS MEDICA has distribution agreements in Denmark, Sweden, Netherland, Belgium. As for Denmark, the Company has been selling medical devices on the following web shops; matas.dk, webapoteket.dk, apopro.dk, med24.dk, dinapoteker.dk and their own web shop cosmage.dk.  The company has currently the CANNASEN®CBD Arthritis Gel and Psoriasis Gel on shelf in Matas.

Today, the Company announces that three additional products have been launched on Matas. The additional products are available on Matas webshop and include CANNASEN®CBD Pain Patch, Protective Nasal Gel and CBD PSOR+ATOPIC Lotion. Matas is a nationwide retail company that offers a wide range of beauty and health products as well as over-the-counter medicines. There are almost 250 stores throughout Denmark, of which the above CANNASEN products is present at their medical stores, a total of 186 stores.

Link to the products on Matas: www.matas.dk/cannasen